dr. nancy l. lewis explains the implications of the grid study
Published 11 years ago • 69 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
1:18
dr. nancy l. lewis on resistance among gist patients and regorafenib
-
1:20
dr. nancy l. lewis on targeted therapies in gastroesophageal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:13
nancy lewis harmon
-
59:12
einstein, condensed matter physics, nanoscience & superconductivity - 2011 dickson prize lecture
-
1:42:44
batteries of the future; solid electrolytes & li-rich cathodes | k. edstrom & s. islam | storagex
-
2:54
the technology s-curve | innovation strategy, 15.910
-
2:39
understanding the kidneys
-
1:14
nancy keating | cancer research from diagnosis to end of life
-
10:13
novel hypothesis - generating analysis of intervals between seizure clusters: neurelis inc.
-
6:00
science is fun! but can it explain everything? join dr. ard louis at the veritas forum
-
1:24
improving the diagnosis of bladder cancer in the bladderpath study
-
2:38
third-line therapy for gist
-
1:07:29
from curie & schrödinger, to curing cancer: medical physics — prof. annette haworth
-
2:32
cal-light: a calcium- and light-gated switch system
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
1:04:03
nancy stokey | technology diffusion: evidence and theory
-
8:18
current state and future directions in bladder cancer
-
2:01
lesson 19 - voltage divider circuits, part 2 (engineering circuit analysis)